Last year, these treatments accounted for 75% of the $236B in annual sales set to vanish with the loss of exclusivity.
Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients ...
U.S. President Donald Trump's embrace of an old generic drug called leucovorin for use against a rare disorder that causes ...
Stocktwits on MSN
Why Does Cantor Fitzgerald See Over 1,000% Potential Upside For Cabaletta Bio Stock?
Cantor Fitzgerald’s new price target on CABA represents over 1,000% potential upside to the stock’s closing price on Thursday ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor ...
Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...
The poster will be made available on the Presentations & Research page of Unicycive’s website following the poster ...
Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...
The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback